NetworkNewsBreaks

WednesdayOct 25, 2023 3:35 pm

NetworkNewsBreaks – IMARC 2023 to Showcase the Latest AI Applications and Strategies

IBN’s MiningNewsWire delves into trends in artificial intelligence (“AI”) in a recent article titled, “From Changing a Tire to Uncovering the Next Lode: How AI Is Revolutionizing the Mining Industry.” The piece discusses the mining industry’s positioning at the forefront of technological progress, with the adoption of AI in recent years emerging as a game changer, allowing for more efficient exploration, taking automation to new levels, generating greater yields, dramatically improving safety, and maximizing extraction, maintenance and operational performance. Featured within the publication are details surrounding the 2023 International Mining and Resources Conference (“IMARC”), which is taking place in Sydney,…

Continue Reading

WednesdayOct 25, 2023 3:25 pm

NetworkNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) Schedules Q3 2023 Earnings Call

D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software and services, has announced plans to report on its third-quarter financial results for the period ended Sept. 30, 2023. The company will issue its third quarter earnings press release before market opens on Nov. 9, 2023. In addition, D-Wave Quantum CEO Alan Baratz and CFO John Markovich will host a conference call on the same day; the call will begin at 8 a.m. ET. During the call, company officials will discuss D-Wave Quantum financial results as well as its business outlook. Those interested can access by call by dialing…

Continue Reading

WednesdayOct 25, 2023 12:54 pm

NetworkNewsBreaks – Canada Nickel Company Inc. (TSX.V: CNC) (OTCQX: CNIKF) Featured in Bell2Bell Podcast

Canada Nickel (TSX.V: CNC) (OTCQX: CNIKF), a company working to advance the next generation of high quality nickel sulphide projects to feed the high growth electric vehicle and stainless steel markets, was featured in the latest episode of the Bell2Bell Podcast, a part of IBN’s sustained effort to provide specialized content distribution via widespread syndication channels. Mark Selby, CEO and director of Canada Nickel, joined the latest episode to discuss the company’s projects, including its recent news announcing the positive bankable feasibility study for its Crawford Nickel Sulphide Project. “It’s a major milestone for the company – $2.5 billion after-tax…

Continue Reading

WednesdayOct 25, 2023 12:07 pm

NetworkNewsBreaks – Safety Shot (NASDAQ: SHOT) Granted Second U.S. Patent for JW-700 Treatment Designed for $1.5B Hair-Growth Market

Safety Shot (NASDAQ: SHOT), a wellness and functional beverage company, announced a “significant milestone” in its development of treatments for androgenetic alopecia, or hair loss: the granting of a second U.S. patent issued for JW-700, a topical treatment designed to improve minoxidil’s efficacy. The patent was issued by the U.S. Patent and Trademark Office. The patent adds to the growing global intellectual property (“IP”) estate for Safety Shots Legacy products. According to the announcement, minoxidil is a common treatment of hair loss sold under brand names including Rogaine(R) and Hair Regrowth for Men(R), and Safety Shot’s JW-700 has been shown to…

Continue Reading

WednesdayOct 25, 2023 11:10 am

NetworkNewsBreaks — Reflex Advanced Materials Corp. (CSE: RFLX) (OTCQB: RFLXF) (FSE: HF2) Notes Increase of Nonbrokered Offering

Reflex Advanced Materials (CSE: RFLX) (OTCQB: RFLXF) (FSE: HF2), a mineral exploration company, has upsized its nonbrokered private placement financing, which had been announced initially in August. The first two tranches of the offering closed earlier this month, and the offering now consists of up to 7,500,000 units of the company offered at $0.20 per unit, resulting in an anticipated $1.5 million gross proceeds; the original projection was for $1 million. According to the announcement, each unit of the offering includes one common share in the capital of the company and one-half of one share purchase warrant, with each whole…

Continue Reading

WednesdayOct 25, 2023 10:47 am

NetworkNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Enters Agreements for Private Placement, Preferred Investment Options

InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development, manufacturing and commercialization of rare cannabinoids and cannabinoid analogs, has entered into a definitive agreement for the issue and sale of more than 3 million common shares, or prefunded warrants in lieu thereof. Specifically, the company agreed to a private placement of 3,012,049 common shares priced at $0.83 per share. In addition, the company entered an agreement for an associated preferred investment option as well as a definitive agreement regarding specific outstanding preferred investment options issued in November 2022. The announcement outlines specifics of the agreement. The company also…

Continue Reading

TuesdayOct 24, 2023 12:37 pm

NetworkNewsBreaks – International Mining and Resources Conference 2023 Agenda Has ‘Something for Everyone’

The International Mining and Resources Conference (“IMARC”) is forecast to be the largest ever, with mining and resource leaders coming from around the world. The three-day event is slated for Oct. 31–Nov. 2, 2023, and will be held in Sydney. This year’s agenda features more than 520 speakers and 120-plus exhibitors. Expert presenters come from global giants such as BHP, Fortescue, MMG, Gold Fields, Wesfarmers, Worley, Perenti, IGO, the U.S. Departments of Energy and Defense, and the ICMM. Speakers and presentations will include topics such as Digital Transformation and Innovation; Sustainability, Social Value, Environmental Resilience, People and Culture; Trade, Investment…

Continue Reading

TuesdayOct 24, 2023 12:31 pm

NetworkNewsBreaks – HyperSense Software Expands Footprint to Bring Innovative Solutions to the Windy City

HyperSense, a renowned global provider of software development and digital transformation solutions, today announced the opening of its new office in Chicago, marking a significant expansion in its U.S. presence. The move demonstrates HyperSense’s commitment to bringing its unparalleled expertise closer to clients in diverse industries including fintech, health care, e-learning, manufacturing and IT/software. The expansion comes on the heels of HyperSense’s continued recognition with several “Top Development Company” awards from Clutch and prestigious membership in the Forbes Business Council. “Chicago is a vibrant hub of innovation and business growth,” said Andrei Neacsu, CTO of HyperSense. “We are thrilled to…

Continue Reading

TuesdayOct 24, 2023 12:22 pm

NetworkNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) to Advance INM-901 Following Positive Proof-of-Concept Results

InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development, manufacturing and commercialization of rare cannabinoids and cannabinoid analogs, today announced its selection of a lead Alzheimer’s disease drug candidate, named INM-901, following positive results from several proof-of-concept studies in a validated Alzheimer’s treatment model. InMed will be advancing cannabinoid analog INM-901 in its pharmaceutical drug development program. “The most recent studies of INM-901 demonstrate promising disease-modifying effects in an Alzheimer’s disease treatment model,” said Dr. Eric Hsu, InMed’s SVP of preclinical research and development. “We are optimistic that the next stage of studies will continue to show how…

Continue Reading

TuesdayOct 24, 2023 12:12 pm

NetworkNewsBreaks — Longeveron Inc. (NASDAQ: LGVN; LGVNR) Top-Line Results from Phase 2a Trial Spotlighted in Latest NNA Release

Longeveron (NASDAQ: LGVN), a clinical-stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions such as hypoplastic left heart syndrome (“HLHS”), Alzheimer’s disease and Aging-Related Frailty, is featured in a recent NetworkNewsAudio (“NNA”) broadcast. The segment focuses on the company’s most recent announcement of its topline results from the CLEAR Mind phase 2a clinical trial of LGVN’s Lomecel-B(TM) for the treatment of mild Alzheimer's disease. According to the segment, the Lomecel-B study met its primary safety endpoint and is supported by lack of deterioration in cognitive or atrophy signals. The encouraging results will be used as a foundation…

Continue Reading